Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2121209161', 'doi': 'https://doi.org/10.3109/10428194.2010.507416', 'title': 'Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country', 'display_name': 'Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country', 'publication_year': 2010, 'publication_date': '2010-09-20', 'ids': {'openalex': 'https://openalex.org/W2121209161', 'doi': 'https://doi.org/10.3109/10428194.2010.507416', 'mag': '2121209161', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/20849386'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.3109/10428194.2010.507416', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S27064115', 'display_name': 'Leukemia & lymphoma/Leukemia and lymphoma', 'issn_l': '1026-8022', 'issn': ['1026-8022', '1029-2403', '1042-8194'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5108395616', 'display_name': 'Kunjahari Medhi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210161040', 'display_name': 'DR. B.R.A. Institute Rotary Cancer Hospital', 'ror': 'https://ror.org/0560xr487', 'country_code': 'IN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210161040', 'https://openalex.org/I63739035']}, {'id': 'https://openalex.org/I63739035', 'display_name': 'All India Institute of Medical Sciences', 'ror': 'https://ror.org/02dwcqs71', 'country_code': 'IN', 'type': 'education', 'lineage': ['https://openalex.org/I63739035']}], 'countries': ['IN'], 'is_corresponding': False, 'raw_author_name': 'Kunjahari Medhi', 'raw_affiliation_strings': ['Department of Medical Oncology, Institute Rotary Cancer Hospital, All-India Institute of Medical Sciences, New Delhi, India'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Oncology, Institute Rotary Cancer Hospital, All-India Institute of Medical Sciences, New Delhi, India', 'institution_ids': ['https://openalex.org/I4210161040', 'https://openalex.org/I63739035']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108073537', 'display_name': 'Vinod Raina', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210161040', 'display_name': 'DR. B.R.A. Institute Rotary Cancer Hospital', 'ror': 'https://ror.org/0560xr487', 'country_code': 'IN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210161040', 'https://openalex.org/I63739035']}, {'id': 'https://openalex.org/I63739035', 'display_name': 'All India Institute of Medical Sciences', 'ror': 'https://ror.org/02dwcqs71', 'country_code': 'IN', 'type': 'education', 'lineage': ['https://openalex.org/I63739035']}], 'countries': ['IN'], 'is_corresponding': False, 'raw_author_name': 'Vinod Raina', 'raw_affiliation_strings': ['Department of Medical Oncology, Institute Rotary Cancer Hospital, All-India Institute of Medical Sciences, New Delhi, India'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Oncology, Institute Rotary Cancer Hospital, All-India Institute of Medical Sciences, New Delhi, India', 'institution_ids': ['https://openalex.org/I4210161040', 'https://openalex.org/I63739035']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100704933', 'display_name': 'Lalit Kumar', 'orcid': 'https://orcid.org/0000-0002-9210-2500'}, 'institutions': [{'id': 'https://openalex.org/I4210161040', 'display_name': 'DR. B.R.A. Institute Rotary Cancer Hospital', 'ror': 'https://ror.org/0560xr487', 'country_code': 'IN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210161040', 'https://openalex.org/I63739035']}, {'id': 'https://openalex.org/I63739035', 'display_name': 'All India Institute of Medical Sciences', 'ror': 'https://ror.org/02dwcqs71', 'country_code': 'IN', 'type': 'education', 'lineage': ['https://openalex.org/I63739035']}], 'countries': ['IN'], 'is_corresponding': False, 'raw_author_name': 'Lalit Kumar', 'raw_affiliation_strings': ['Department of Medical Oncology, Institute Rotary Cancer Hospital, All-India Institute of Medical Sciences, New Delhi, India'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Oncology, Institute Rotary Cancer Hospital, All-India Institute of Medical Sciences, New Delhi, India', 'institution_ids': ['https://openalex.org/I4210161040', 'https://openalex.org/I63739035']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100704082', 'display_name': 'Atul Sharma', 'orcid': 'https://orcid.org/0000-0003-2627-5814'}, 'institutions': [{'id': 'https://openalex.org/I63739035', 'display_name': 'All India Institute of Medical Sciences', 'ror': 'https://ror.org/02dwcqs71', 'country_code': 'IN', 'type': 'education', 'lineage': ['https://openalex.org/I63739035']}, {'id': 'https://openalex.org/I4210161040', 'display_name': 'DR. B.R.A. Institute Rotary Cancer Hospital', 'ror': 'https://ror.org/0560xr487', 'country_code': 'IN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210161040', 'https://openalex.org/I63739035']}], 'countries': ['IN'], 'is_corresponding': False, 'raw_author_name': 'Atul Sharma', 'raw_affiliation_strings': ['Department of Medical Oncology, Institute Rotary Cancer Hospital, All-India Institute of Medical Sciences, New Delhi, India'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Oncology, Institute Rotary Cancer Hospital, All-India Institute of Medical Sciences, New Delhi, India', 'institution_ids': ['https://openalex.org/I63739035', 'https://openalex.org/I4210161040']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000530935', 'display_name': 'Sameer Bakhshi', 'orcid': 'https://orcid.org/0000-0001-9367-4407'}, 'institutions': [{'id': 'https://openalex.org/I4210161040', 'display_name': 'DR. B.R.A. Institute Rotary Cancer Hospital', 'ror': 'https://ror.org/0560xr487', 'country_code': 'IN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210161040', 'https://openalex.org/I63739035']}, {'id': 'https://openalex.org/I63739035', 'display_name': 'All India Institute of Medical Sciences', 'ror': 'https://ror.org/02dwcqs71', 'country_code': 'IN', 'type': 'education', 'lineage': ['https://openalex.org/I63739035']}], 'countries': ['IN'], 'is_corresponding': False, 'raw_author_name': 'Sameer Bakhshi', 'raw_affiliation_strings': ['Department of Medical Oncology, Institute Rotary Cancer Hospital, All-India Institute of Medical Sciences, New Delhi, India'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Oncology, Institute Rotary Cancer Hospital, All-India Institute of Medical Sciences, New Delhi, India', 'institution_ids': ['https://openalex.org/I4210161040', 'https://openalex.org/I63739035']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5032576109', 'display_name': 'Ritu Gupta', 'orcid': 'https://orcid.org/0000-0001-5364-4086'}, 'institutions': [{'id': 'https://openalex.org/I4210161040', 'display_name': 'DR. B.R.A. Institute Rotary Cancer Hospital', 'ror': 'https://ror.org/0560xr487', 'country_code': 'IN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210161040', 'https://openalex.org/I63739035']}, {'id': 'https://openalex.org/I63739035', 'display_name': 'All India Institute of Medical Sciences', 'ror': 'https://ror.org/02dwcqs71', 'country_code': 'IN', 'type': 'education', 'lineage': ['https://openalex.org/I63739035']}], 'countries': ['IN'], 'is_corresponding': False, 'raw_author_name': 'Ritu Gupta', 'raw_affiliation_strings': ['Laboratory Oncology Unit, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.'], 'affiliations': [{'raw_affiliation_string': 'Laboratory Oncology Unit, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.', 'institution_ids': ['https://openalex.org/I4210161040', 'https://openalex.org/I63739035']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5108107638', 'display_name': 'Rajive Kumar', 'orcid': 'https://orcid.org/0000-0002-0406-7646'}, 'institutions': [{'id': 'https://openalex.org/I4210161040', 'display_name': 'DR. B.R.A. Institute Rotary Cancer Hospital', 'ror': 'https://ror.org/0560xr487', 'country_code': 'IN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210161040', 'https://openalex.org/I63739035']}, {'id': 'https://openalex.org/I63739035', 'display_name': 'All India Institute of Medical Sciences', 'ror': 'https://ror.org/02dwcqs71', 'country_code': 'IN', 'type': 'education', 'lineage': ['https://openalex.org/I63739035']}], 'countries': ['IN'], 'is_corresponding': False, 'raw_author_name': 'Rajive Kumar', 'raw_affiliation_strings': ['Laboratory Oncology Unit, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.'], 'affiliations': [{'raw_affiliation_string': 'Laboratory Oncology Unit, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.', 'institution_ids': ['https://openalex.org/I4210161040', 'https://openalex.org/I63739035']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.516, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 10, 'citation_normalized_percentile': {'value': 0.755268, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 84, 'max': 85}, 'biblio': {'volume': '51', 'issue': '10', 'first_page': '1850', 'last_page': '1854'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11215', 'display_name': 'Chronic Myeloid Leukemia Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11215', 'display_name': 'Chronic Myeloid Leukemia Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12600', 'display_name': 'Eosinophilic Disorders and Syndromes', 'score': 0.996, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9876, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/imatinib-mesylate', 'display_name': 'Imatinib Mesylate', 'score': 0.8509277}], 'concepts': [{'id': 'https://openalex.org/C2777583451', 'wikidata': 'https://www.wikidata.org/wiki/Q177094', 'display_name': 'Imatinib', 'level': 3, 'score': 0.90948904}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8548062}, {'id': 'https://openalex.org/C3019892230', 'wikidata': 'https://www.wikidata.org/wiki/Q177094', 'display_name': 'Imatinib mesylate', 'level': 4, 'score': 0.8509277}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.710852}, {'id': 'https://openalex.org/C2778729363', 'wikidata': 'https://www.wikidata.org/wiki/Q11688946', 'display_name': 'Myeloid leukemia', 'level': 2, 'score': 0.6851651}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.5762288}, {'id': 'https://openalex.org/C2778820342', 'wikidata': 'https://www.wikidata.org/wiki/Q906415', 'display_name': 'Tyrosine-kinase inhibitor', 'level': 3, 'score': 0.48488292}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.13444495}], 'mesh': [{'descriptor_ui': 'D015464', 'descriptor_name': 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000293', 'descriptor_name': 'Adolescent', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D001549', 'descriptor_name': 'Benzamides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002648', 'descriptor_name': 'Child', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005500', 'descriptor_name': 'Follow-Up Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017495', 'descriptor_name': 'Hyperpigmentation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017495', 'descriptor_name': 'Hyperpigmentation', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D017496', 'descriptor_name': 'Hypopigmentation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017496', 'descriptor_name': 'Hypopigmentation', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D000068877', 'descriptor_name': 'Imatinib Mesylate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007194', 'descriptor_name': 'India', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D053208', 'descriptor_name': 'Kaplan-Meier Estimate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015464', 'descriptor_name': 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009503', 'descriptor_name': 'Neutropenia', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D009503', 'descriptor_name': 'Neutropenia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013921', 'descriptor_name': 'Thrombocytopenia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013921', 'descriptor_name': 'Thrombocytopenia', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D055815', 'descriptor_name': 'Young Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.3109/10428194.2010.507416', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S27064115', 'display_name': 'Leukemia & lymphoma/Leukemia and lymphoma', 'issn_l': '1026-8022', 'issn': ['1026-8022', '1029-2403', '1042-8194'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/20849386', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Partnerships for the goals', 'score': 0.47, 'id': 'https://metadata.un.org/sdg/17'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 10, 'referenced_works': ['https://openalex.org/W1964358866', 'https://openalex.org/W1984617193', 'https://openalex.org/W2030154801', 'https://openalex.org/W2060718225', 'https://openalex.org/W2091005492', 'https://openalex.org/W2157743993', 'https://openalex.org/W2170355664', 'https://openalex.org/W2291690946', 'https://openalex.org/W2337803710', 'https://openalex.org/W2342728849'], 'related_works': ['https://openalex.org/W3116441850', 'https://openalex.org/W3030758756', 'https://openalex.org/W2718479979', 'https://openalex.org/W2392515536', 'https://openalex.org/W2158958466', 'https://openalex.org/W2157069029', 'https://openalex.org/W2123135404', 'https://openalex.org/W2120077570', 'https://openalex.org/W2070391470', 'https://openalex.org/W2057257241'], 'abstract_inverted_index': {'Imatinib': [0, 181], 'mesylate,': [1], 'a': [2, 10, 88], 'targeted': [3], 'inhibitor': [4], 'of': [5, 12, 25, 91, 110, 120], 'BCR-ABL': [6], 'tyrosine': [7], 'kinase,': [8], 'is': [9], 'standard': [11], 'care': [13], 'for': [14, 76, 144], 'chronic': [15], 'myeloid': [16], 'leukemia': [17], '(CML).': [18], 'There': [19, 83], 'are': [20], 'few': [21], 'publications': [22], 'on': [23], 'responses': [24, 80], 'patients': [26, 48, 55, 104, 111], 'with': [27, 49, 56, 87, 126], 'CML': [28, 50, 57], 'from': [29, 68], 'the': [30, 36, 62, 145, 177], 'Indian': [31], 'subcontinent.': [32], 'This': [33], 'study': [34], 'analyzed': [35], 'response': [37, 123, 130], 'rate,': [38], 'progression-free': [39], 'survival': [40, 43], '(PFS),': [41], 'overall': [42], '(OS),': [44], 'and': [45, 78, 96, 102, 131, 139, 150, 156, 161, 172], 'toxicities': [46], 'in': [47, 154, 158, 176, 185], 'given': [51], 'imatinib.': [52], 'Analysis': [53], 'included': [54], 'who': [58], 'received': [59, 98, 105], 'imatinib': [60, 106, 163, 179], 'under': [61], 'GIPAP': [63], 'program': [64], 'at': [65, 141], 'our': [66, 186], 'institution': [67], 'January': [69], '2002': [70], 'to': [71], 'December': [72], '2008.': [73], 'Standard': [74], 'criteria': [75], 'hematological': [77, 114], 'cytogenetic': [79, 122, 129, 134], 'were': [81, 84, 165, 174], 'used.': [82], '400': [85], 'patients,': [86], 'median': [89, 142], 'follow-up': [90, 143], '47': [92], 'months.': [93], 'One': [94], 'hundred': [95], 'seventy': [97], 'prior': [99, 159], 'non-imatinib': [100, 160], 'therapy': [101], '230': [103], 'upfront.': [107], 'Ninety-five': [108], 'percent': [109], 'achieved': [112], 'complete': [113, 128], 'response.': [115, 135], 'The': [116, 136], 'cumulative': [117], 'best': [118], 'rate': [119], 'major': [121], 'was': [124, 148, 182], '72%,': [125], '53%': [127], '19%': [132], 'partial': [133], 'estimated': [137], 'PFS': [138, 155, 171], 'OS': [140, 157, 173], 'whole': [146], 'group': [147], '76%': [149], '94%,': [151], 'respectively.': [152], 'Differences': [153], 'upfront': [162, 178], 'groups': [164], 'not': [166], 'statistically': [167], 'significant.': [168], 'However,': [169], 'better': [170], 'seen': [175], 'group.': [180], 'well': [183], 'tolerated': [184], 'study.': [187]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2121209161', 'counts_by_year': [{'year': 2020, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-13T04:39:28.226333', 'created_date': '2016-06-24'}